What dose of domperidone should be given to a 13.6kg, 2-year-old child for abdominal pain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Domperidone Dosing for a 13.6 kg, 2-Year-Old Child

For a 13.6 kg, 2-year-old child with abdominal pain, administer domperidone at 0.25 mg/kg per dose (3.4 mg), which equals approximately 0.7 mL of the 5 mg/mL drops, given three times daily 15-30 minutes before meals.

Dosing Calculation and Rationale

The standard pediatric dose of domperidone is 0.25 mg/kg per dose, administered 3 times daily before meals 1. For this 13.6 kg child:

  • Dose per administration: 0.25 mg/kg × 13.6 kg = 3.4 mg
  • Volume per dose: 3.4 mg ÷ 5 mg/mL = 0.68 mL (round to 0.7 mL)
  • Frequency: Three times daily, 15-30 minutes before meals
  • Total daily dose: 10.2 mg/day (well within safe limits)

Evidence Supporting Use in Pediatric Abdominal Pain

Domperidone has demonstrated efficacy specifically for functional abdominal pain in children aged 5-12 years, with significant improvement in abdominal pain severity (54.1% reduction vs 24.7% placebo, P = 0.008) and patient-reported general improvement (74% vs 50% placebo, P = 0.013) at 8 weeks 1.

  • At 6-month follow-up, 60% of children treated with domperidone achieved cure compared to 38% with placebo (P = 0.028) 1
  • The medication acts as a prokinetic agent through dopamine-2 receptor antagonism, improving gastric motility without crossing the blood-brain barrier significantly 2
  • No intervention-related adverse effects were reported in the pediatric trial 1

Administration Guidelines

Timing is critical for optimal efficacy:

  • Administer 15-30 minutes before each of the three main meals 1
  • This pre-meal timing allows the prokinetic effect to enhance gastric emptying when food is consumed
  • The medication improves symptoms through effects on the chemoreceptor trigger zone and motor function of the stomach and small intestine 2

Safety Profile and Monitoring

Domperidone has an excellent safety profile in children due to minimal blood-brain barrier penetration, unlike metoclopramide which causes neurological side effects 2. In the largest pediatric study:

  • No adverse effects were reported in children with functional abdominal pain 1
  • In adult studies, side effects occurred in approximately 12% of patients, most commonly headache, tachycardia/palpitations, and diarrhea 3
  • Only 12% of adults discontinued treatment due to side effects 3

Monitor for:

  • Symptom improvement within 3 days of starting treatment (when improvement typically begins) 4
  • Rare cardiac effects (palpitations), though uncommon in pediatric populations
  • Headache or gastrointestinal symptoms

Clinical Pitfalls to Avoid

Common dosing errors:

  • Do not confuse the concentration: 5 mg/mL means each mL contains 5 mg, not 5 mg per 5 mL
  • Do not use "every 8 hours" dosing—domperidone for gastroparesis/abdominal pain is dosed TID (three times daily) before meals, not on a strict 8-hour schedule 1, 3
  • Ensure pre-meal administration timing; giving with or after meals reduces efficacy

Age consideration: While the primary pediatric study enrolled children 5-12 years old 1, domperidone is used in younger children at weight-based dosing of 0.25 mg/kg per dose. At 2 years old, this child falls within the acceptable age range for off-label use with appropriate monitoring.

Expected Outcomes

Symptom improvement timeline 4:

  • Initial improvement typically occurs by day 3 of treatment
  • Significant reduction in abdominal pain severity by week 8
  • Sustained benefit through 6 months of follow-up in pediatric studies 1

Primary symptoms that improve include postprandial fullness, nausea, upper abdominal pain, and overall gastroparesis symptoms 4, 1, 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.